References
- Adam S, Suzzi D, Radeke C, Khinast JG. An integrated quality by design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation. Eur J Pharm Sci 2011;42:106–15
- Yu LX, Amidon G, Khan MA, et al. Understanding pharmaceutical quality by design. AAPS J 2014;16:771–83
- Stocker E, Toschkoff G, Sacher S, Khinast JG. Use of mechanistic simulations as a quantitative risk-ranking tool within the quality by design framework. Int J Pharm 2014;475:245–55
- Andersson M, Ringberg A, Gustafsson C. Multivariate methods in tablet formulation suitable for early drug development: predictive models from a screening design of several linked responses. Chemom Intell Lab Syst 2007;87:125–30
- Gabrielsson J, Lindberg N-O, Lundstedt T. Multivariate methods in pharmaceutical applications. J Chemom 2002;16:141–60
- Choi DH, Shin S, Viet Truong NK, Jeong SH. A new experimental design method to optimize formulations focusing on a lubricant for hydrophilic matrix tablets. Drug Dev Ind Pharm 2012;38:1117–27
- Nekkanti V, Marwah A, Pillai R. Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE). Drug Dev Ind Pharm 2015;41:124–30
- Sternberger-Rützel E, Runft W, Beck M, et al. Quality by design: concept for the proof-of-principle testing regarding automated microdosing. Pharm Ind 2012;74:145–54
- Xie LIN, Wu H, Shen M, et al. Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester. J Pharm Sci 2008;97:4485–97
- Charoo NA, Shamsher AAA, Zidan AS, Rahman Z. Quality by design approach for formulation development: a case study of dispersible tablets. Int J Pharm 2012;423:167–78
- Huang J, Kaul G, Cai C, et al. Quality by design case study: an integrated multivariate approach to drug product and process development. Int J Pharm 2009;382:23–32
- Faulhammer E, Fink M, Llusa M, et al. Low-dose capsule filling of inhalation products: critical material attributes and process parameters. Int J Pharm 2014;473:617–26
- Osorio JG, Muzzio FJ. Effects of powder flow properties on capsule filling weight uniformity. Drug Dev Ind Pharm 2013;39:1464–75
- Edwards D. Applications of capsule dosing techniques for use in dry powder inhalers. Ther Deliv 2010;1:195–201
- Eskandar F, Lejeune M, Edge S. Low powder mass filling of dry powder inhalation formulations. Drug Dev Ind Pharm 2011;37:24–32
- Marriott C, Frijlink HW. Lactose as a carrier for inhalation products: breathing new life into an old carrier. Preface. Adv Drug Deliv Rev 2012;64:217–19
- Peeters E, De Beer T, Vervaet C, Remon J. Reduction of tablet weight variability by optimizing paddle speed in the forced feeder of a high-speed rotary tablet press. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.884121
- Boersen N, Carvajal MT, Morris KR, et al. The influence of API concentration on the roller compaction process: modeling and prediction of the post compacted ribbon, granule and tablet properties using multivariate data analysis. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.958754
- Marasanapalle VP, Crison JR, Devarakonda KR, et al. Based on their biopharmaceutical characteristics. Drug Dev Ind Pharm 2011;37:1429–38
- Adesina SK, Wight SA, Akala EO. Optimization of the fabrication of novel stealth PLA-based nanoparticles by dispersion polymerization using D-optimal mixture design. Drug Dev Ind Pharm 2014;40:1547–56
- Morales JO, Joks GM, Lamprecht A, et al. A design of experiments to optimize a new manufacturing process for high activity protein-containing submicron particles. Drug Dev Ind Pharm 2013;39:1793–801
- Llusa M, Faulhammer E, Biserni S, et al. The effect of capsule-filling machine vibrations on average fill weight. Int J Pharm 2013;454:381–7
- Faulhammer E, Llusa M, Radeke C, et al. The effects of material attributes on capsule fill weight and weight variability in dosator nozzle machines. Int J Pharm 2014;471:332–8
- Wold S, Eriksson L, Trygg J, Kettaneh N. The PLS method – partial least squares projections to latent structures – and its applications in industrial RDP (research, development, and production). Technical Report. Umea University, Sweden, 2004;1:1–44
- Lundstedt T, Seifert E, Abramo L, et al. Experimental design and optimization. Chemom Intell Lab Syst 1998;42:3–40
- Eriksson L, Johansson E, Kettaneh-Wold N, et al. Design of experiments principles and applications. 3rd ed. Umea: Umetrics Academy; 2006
- Baş D, Boyacı İH. Modeling and optimization I: usability of response surface methodology. J Food Eng 2007;78:836–45
- Gómez-Gaete C, Bustos GL, Godoy RR, et al. Successful factorial design for the optimization of methylprednisolone encapsulation in biodegradable nanoparticles. Drug Dev Ind Pharm 2013;39:310–20
- Bezerra MA, Santelli RE, Oliveira EP, et al. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta 2008;76:965–77
- Ren S, Mu H, Alchaer F, et al. Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology. Drug Dev Ind Pharm 2013;39:799–806
- Shen C, Shen B, Xu H, et al. Formulation and optimization of a novel oral fast dissolving film containing drug nanoparticles by Box-Behnken design-response surface methodology. Drug Dev Ind Pharm 2014;40:649–56
- Lourenço V, Lochmann D, Reich G, et al. A quality by design study applied to an industrial pharmaceutical fluid bed granulation. Eur J Pharm Biopharm 2012;81:438–47
- Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 2008;25:781–91
- Lepore J, Spavins J. PQLI design space. J Pharm Innov 2008;3:79–87
- Rathore AS. Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol 2009;27:546–53
- ICH, FDA. Guidance for Industry Q8, Q9 and Q11. Guid Ind Q8,Q9, Q10 – Append Q As from Train Sess Guid Ind. 2012. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM313094.pdf [last accessed April 2014]